Jennifer Trevor is a Respiratory physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 74 publications with 2,421 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1717 6th Ave S
Birmingham, AL 352331801
Telephone
800-822-8816Registry record last updated 29 Jun 2023.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20253 payments
- GlaxoSmithKline, LLC.Program year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
58.9%Corticosteroid25.7%Trelegy Ellipta40%Budesonide-Formoterol Fumarate22%Breo Ellipta18%Fluticasone Propionate10%Symbicort10%Part D<11 patientsbeta2-Adrenergic Agonist10.5%Albuterol Sulfate Hfa100%Part D≥13 patients+ 4 more classes in this area
Dermatology
25%Interleukin-4 Receptor alpha Antagonist25%Dupixent Pen58%Dupixent Syringe42%Part D<11 patientsMetabolism & gastrointestinal
12.1%Corticosteroid8.4%Prednisone100%Part D≥18 patientsProton pump inhibitor3.7%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Asthma biologic effectiveness by age and sex in the US CHRONICLE study
Journal of Allergy and Clinical Immunology Global
2025 - Small Extracellular Vesicle Signaling and Mitochondrial Transfer Reprograms T Helper Cell Function in Human Asthma
bioRxiv (Cold Spring Harbor Laboratory)
2024 - Quality of Life Improvements with Biologic Initiation Among Subspecialist-Treated US Patients with Severe Asthma
Journal of Asthma and Allergy
2024 - Biologic outcomes in U.S. Hispanic and Black patients with severe asthma
The Journal of Allergy and Clinical Immunology In Practice
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”